Neocortical cholinergic neurons in elderly people

Area of Science:

• Neuroscience
• Gerontology
• Neuropathology

Background:

• The cholinergic system plays a crucial role in cognitive function.
• Age-related cognitive decline and dementia involve alterations in neurotransmitter systems.
• Understanding changes in the cholinergic system is vital for developing effective dementia treatments.

Purpose of the Study:

• To investigate changes in presynaptic and postsynaptic cholinergic markers in the aging brain.
• To differentiate cholinergic system alterations in various forms of dementia, including Alzheimer's disease and Pick's disease.
• To evaluate the potential therapeutic implications of these findings for dementia treatment.

Main Methods:

• Measurement of choline acetyltransferase activity (presynaptic marker) in post-mortem brain tissue.
• Assessment of high-affinity binding of cholinergic antagonists (postsynaptic marker) in brain tissue.
• Comparison of marker levels between mentally normal elderly individuals and patients with different types of dementia.

Main Results:

• Muscarinic receptor binding sites in the frontal cortex decreased with age, specifically in individuals without significant senile degeneration.
• Preliminary data indicated reduced receptor binding sites in the temporal lobe in Pick's disease.
• Cholinergic markers were not significantly reduced in mixed senile and vascular dementia.
• Non-vascular senile dementia of the Alzheimer type showed selective depletion of the presynaptic marker.

Conclusions:

• Alzheimer's disease, particularly the non-vascular senile form, is characterized by selective depletion of presynaptic cholinergic markers.
• The findings suggest that centrally acting anticholinesterase agents could be beneficial, especially in the early stages of Alzheimer's disease.
• Further research into cholinergic system deficits may lead to targeted therapeutic strategies for dementia.